ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 6 of 29

7 Î Methadone is recommended for patients who may benefit from daily dosing and supervision in an OTP, or for patients for whom buprenorphine for the treatment of OUD has been used unsuccessfully in an OTP or OBOT setting. Î NEW – Opioid dosing guidelines developed for chronic pain, expressed in morphine milligram equivalents (MME), are not applicable to medications for the treatment of OUDs. Î Oral naltrexone for the treatment of OUD is often adversely affected by poor medication adherence and should NOT be used except under very limited circumstances. • Clinicians should reserve its use for patients who would be able to comply with special techniques to enhance their adherence, for example, observed dosing. • Extended-release injectable naltrexone reduces, but does not eliminate, issues with medication adherence. Î The Prescription Drug Monitoring Program 5 (PDMP) should be checked regularly for the purpose of confirming medication adherence and to monitor for the prescribing of other controlled substances. Î NEW – Naloxone, for the reversal of opioid overdose, should be provided to patients being treated for, or with a history of, OUD. Patients and family members/significant others should be trained in the use of naloxone in overdose. Treating Opioid Withdrawal Î Using methadone or buprenorphine for opioid withdrawal management is recommended over abrupt cessation of opioids. Abrupt cessation of opioids may lead to strong cravings and/or acute withdrawal syndrome, which can put the patient at risk for relapse, overdose, and overdose death. Î Opioid withdrawal management (i.e., detoxification) on its own, without ongoing treatment for OUD, is not a treatment method for OUD and is NOT recommended. • Patients should be advised about the risk of relapse and other safety concerns, including increased risk of overdose and overdose death. • Ongoing maintenance medication, in combination with psychosocial treatment appropriate for the patient's needs, is the standard of care for treating OUD. Î Assessment of a patient undergoing opioid withdrawal management should include a thorough medical history and physical examination focusing on signs and symptoms associated with opioid withdrawal.

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update